Cargando…

Screening for Leishmania specific antibodies among patients with rheumatic diseases treated with biological therapy

Detalles Bibliográficos
Autores principales:	Szabados, Fruzsina, Nielsen, Henrik Vedel, Fuursted, Kurt, Linauskas, Asta, Rasmussen, Claus, Leutscher, Peter Derek Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Research and Education Association 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176213/ https://www.ncbi.nlm.nih.gov/pubmed/35156625 http://dx.doi.org/10.5152/eurjrheum.2022.20105

Ejemplares similares

Entamoeba gingivalis: epidemiology, genetic diversity and association with oral microbiota signatures in North Eastern Tanzania
por: Stensvold, Christen Rune, et al.
Publicado: (2021)

High prevalence of methicillin-resistant Staphylococcus aureus, Giardia, and Blastocystis in asymptomatic Syrian asylum seekers in Denmark during 2016 through 2018
por: Eiset, Andreas Halgreen, et al.
Publicado: (2020)

Evaluation of the NovaLisa™ Leishmania Infantum IgG ELISA in A Reference Diagnostic Laboratory in A Non-Endemic Country
por: Stensvold, Christen Rune, et al.
Publicado: (2019)

Tuberculosis in Children with Rheumatic Diseases Treated with Biologic Disease-Modifying Anti-Rheumatic Drugs
por: Kavadichanda, Chengappa, et al.
Publicado: (2021)

Asylum seekers’ and Refugees’ Changing Health (ARCH) study protocol: an observational study in Lebanon and Denmark to assess health implications of long-distance migration on communicable and non-communicable diseases and mental health
por: Eiset, Andreas Halgreen, et al.
Publicado: (2020)

Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
por: Pizano-Martinez, Oscar, et al.
Publicado: (2023)

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
por: Ceribelli, Angela, et al.
Publicado: (2020)

Retrospective PCR-based species identification of Leishmania in two patients with visceral leishmaniasis in Serbia
por: Dakić, Zorica, et al.
Publicado: (2016)

Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry
por: Linauskas, Asta, et al.
Publicado: (2018)

Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections
por: Jones, Joshua D
Publicado: (2015)

Serosurvey of anti-Leishmania (Leishmania) infantum antibodies in hunting dogs and hunters in Brazil
por: Kmetiuk, Louise Bach, et al.
Publicado: (2021)

Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases
por: Hoffmann, Tobias, et al.
Publicado: (2021)

Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers
por: Rasch, Mads Nyhuus Bendix, et al.
Publicado: (2022)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
por: Michelena, Xabier, et al.
Publicado: (2020)

Treating rheumatic patients with a malignancy
por: Elandt, Katarzyna, et al.
Publicado: (2011)

Case of Rheumatism of the Heart Successfully Treated
por: Russell, James
Publicado: (1814)

Acute Rheumatism Treated with Salicylic Acid
por: Lomax, Joseph D.
Publicado: (1877)

Leishmania amastigotes as targets for drug screening
por: Monte-Alegre, Adriano, et al.
Publicado: (2006)

Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations
por: Knuutila, Aapo, et al.
Publicado: (2020)

Conversion of Tuberculosis Screening Tests During Biologic Therapy Among Veteran Patient Population With Rheumatic Disease
por: Pattanaik, Debendra, et al.
Publicado: (2019)

Complete Genome Sequences of Aerococcus christensenii CCUG 28831(T), Aerococcus sanguinicola CCUG 43001(T), Aerococcus urinae CCUG 36881(T), Aerococcus urinaeequi CCUG 28094(T), Aerococcus urinaehominis CCUG 42038 B(T), and Aerococcus viridans CCUG 4311(T)
por: Carkaci, Derya, et al.
Publicado: (2016)

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
por: Sanchez-Piedra, Carlos, et al.
Publicado: (2020)

New Vistas in the Biology of the Flagellum—Leishmania Parasites
por: Landfear, Scott M.
Publicado: (2022)

Involvement of Leishmania Phosphatases in Parasite Biology and Pathogeny
por: Freitas-Mesquita, Anita Leocadio, et al.
Publicado: (2021)

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry
por: Nabi, Hafsah, et al.
Publicado: (2022)

A Korean rheumatic diseases screening questionnaire.
por: Lee, Hye-Soon, et al.
Publicado: (2003)

Rheumatic Heart Disease Screening Based on Phonocardiogram
por: Asmare, Melkamu Hunegnaw, et al.
Publicado: (2021)

A Case of Rheumatic Suppuration, Successfully Treated
por: Montross, John W.
Publicado: (1807)

Fatal Rheumatic Pericarditis Treated with Cortisone and ACTH
por: Riley, Ian D., et al.
Publicado: (1952)

Cases of Rheumatic Fever Treated by Salicylic Acid
por: Kebble, Alfred
Publicado: (1878)

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Leishmania infantum leishmaniasis in corticosteroid – treated patients
por: Pittalis, Silvia, et al.
Publicado: (2006)

Assessment of a novel bile solubility test and MALDI-TOF for the differentiation of Streptococcus pneumoniae from other mitis group streptococci
por: Slotved, Hans-Christian, et al.
Publicado: (2017)

Systematic Dysphagia Screening of Elderly Persons in the Emergency Department—A Feasibility Study
por: Melgaard, Dorte, et al.
Publicado: (2020)

Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
por: Tawaratsumida, Hiroki, et al.
Publicado: (2017)

Increased intracellular and extracellular oxidant production in phagocytes of rheumatic patients treated with biological therapy – whole blood quantification
por: JančInová, Viera, et al.
Publicado: (2017)

Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
por: Akter, Ripa, et al.
Publicado: (2020)

Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against Leishmania mexicana
por: Vázquez-Jiménez, Lenci K., et al.
Publicado: (2023)

In vitro biological action of aqueous extract from roots of Physalis angulata against Leishmania (Leishmania) amazonensis
por: da Silva, Raquel Raick P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_74k7ho34ft7r03glnc99p3la35